Merit Medical Systems Inc.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Merit Medical Systems Inc.
The 2023 LSX Congress in Boston, MA, heard the views of top-tier medtechs BD, GE HealthCare and Merit Medical as they outlined sustainability compliance strategies and goal setting mechanisms, as summarized in this latest contribution to In Vivo’s rolling series on “The E in ESG.”
The Utah company acquired dialysis and biopsy devices from AngioDynamics for $100m and an access catheter from Bluegrass Vascular for $32.5m.
The confluence of data science and molecular biology fuels expectations among biopharma industry leaders for another year of breakthrough innovation in human therapeutics. More than 70 executives and experts reveal what they are most excited about on the technology front.
Venture capital funding for biotechs remains aplenty even as listed companies’ stock prices drop. Biogen’s Papadopoulos, Fidelity’s Kaul and Gurnet’s and ex-Sanofi Viehbacher deliberate on whether there is a valuation disconnect and if this is the next "tulip mania."
- Diagnostic Equipment & Supplies
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Other Names / Subsidiaries
- Biosphere Medical, Inc.
- Brightwater Medical, Inc.
- Cianna Medical, Inc.
- DFINE, Inc.
- DirectAccess Medical
- Merit Medical Endotek
- Thomas Medical Products, Inc.
- Vascular Insights
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.